Abstract
Glucokinase is one of the key enzymes for the management of diabetes mellitus. Although the literature has reported numerous molecules for lowering the blood glucose level, still no single moiety has been developed for the management of diabetes mellitus. So, there is an urgent need for the development of newer glucokinase activators. To address this issue, we developed a 2D-QSAR model for the development of novel potent glucokinase activators from the 28 reported 4-sulfonyl-2-pyridone molecules. This 2D-QSAR model was further validated through molecular docking simulations and ADMET analysis was also performed on these molecules. The developed 2D-QSAR model was found to be reliable, statistically acceptable, and highly predictable. Molecular docking studies on these molecules further validated our 2D-QSAR model.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
